Drug intelligence / Profile preview

ACI-15916

Development stage
Unknown
Lead developer
AC Immune
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

**ACI-15916** is a radiopharmaceutical and diagnostic agent developed by AC Immune SA. It acts as a modulator of monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B), but its primary clinical application is as a positron emission tomography (PET) tracer for detecting abnormal protein deposits, specifically α-synuclein, in the brain. This makes it relevant for diseases such as Parkinson’s disease, Lewy body dementia, and multiple system atrophy—collectively known as α-synucleinopathies. The drug is currently being evaluated in early-phase clinical trials to assess its safety and effectiveness in measuring pathological α-synuclein accumulation[1][3][8].

Other names
fluorine-18 ACI-15916fluorine18 ACI-15916fluorine 18 ACI-15916
02

Targets

aggregated α-syn (Alpha-synuclein (α-syn))

Beyond the preview

Go deeper on ACI-15916.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACI-15916.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call